Overview
* Crescita Q2 revenue rises 52.5% yr/yr, driven by manufacturing and Croma payment
* Net income reaches C$798k, reversing a loss from prior year
* Adjusted EBITDA improves significantly, reflecting operational efficiencies
Outlook
* Crescita exploring partnerships for Pliaglis in European markets
* Crescita regained Pliaglis rights in several territories after Croma termination
* Company actively seeking new partners for Pliaglis commercialization
Result Drivers
* MANUFACTURING VOLUMES - Revenue increase driven by ramp-up of production volumes with new customer in Manufacturing segment
* TERMINATION PAYMENT - CAD 900,000 added to revenue from mutual termination agreement with Croma
* SKINCARE GROWTH - Skincare segment sales rose due to Aquafolia acquisition and higher export sales
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q2 C$6.23
Revenue mln
Q2 C$964,00
Adjusted 0
EBITDA
Q2 Gross 61.4%
Margin
Q2 C$3.24
Operatin mln
g
Expenses
Q2 C$583,00
Operatin 0
g Income
Press Release:
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)